Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER

Risultato della ricerca: Other

Abstract

No evidence-based guidelines are available for the treatment of Factor VII deficiency. Replacement therapy (RT) is still influenced by different factors as rarity of the disorder, availability and supply of products and economic reasons. All RTs are not exempt of side effects and scanty data is available about the safety of the products currently used. Aim of this study was to analyze adverse events (AEs) of RTs for congenital Factor VII deficiency, as reported in Seven Treatment Evaluation Registry (STER).
Lingua originaleEnglish
Numero di pagine2
Stato di pubblicazionePublished - 2012

Fingerprint Entra nei temi di ricerca di 'Adverse Events in Treatment of Inherited Factor VII Deficiency: Final Analysis of the STER'. Insieme formano una fingerprint unica.

  • Cita questo